Welcome to the Medical Oncology/Hematology Fellowship Program of the University of Maryland Marlene and Stewart Greenebaum Cancer Center (UMGCC).
At UMGCC, we are currently expanding our 50-bed inpatient service to a total of 52 beds. Our service now includes a hematologic malignancies service, a solid tumor service, a hospitalist-run service, a unit dedicated to stem cell transplantation, and an ambulatory care center. Patients admitted to UMGCC are those with known cancer who have expressed a willingness to undergo therapy in a research setting. Patients requiring intensive cardiopulmonary support are managed in the Medical Intensive Care unit. UMGCC also maintains its own hematology, pheresis, stem cell and flow cytometry laboratories, and has its own nursing service and complete inpatient and outpatient pharmacy.
This program, which was established as the Baltimore Cancer Research Center of the National Cancer Institute and became part of the University of Maryland in 1981, has a long, established reputation for excellence in training.
We are committed to providing outstanding clinical training and opportunities for fellows to develop into independent investigators, both in the scientific and clinical arenas.